Literature DB >> 1681517

HaeIII polymorphism within 3' untranslated region of PRAD1.

J Heighway1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681517      PMCID: PMC328934          DOI: 10.1093/nar/19.19.5451-a

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  1 in total

1.  A novel cyclin encoded by a bcl1-linked candidate oncogene.

Authors:  T Motokura; T Bloom; H G Kim; H Jüppner; J V Ruderman; H M Kronenberg; A Arnold
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

  1 in total
  5 in total

1.  Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.

Authors:  S L Holley; G Parkes; C Matthias; U Bockmühl; V Jahnke; K Leder; R C Strange; A A Fryer; P R Hoban
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31.

Authors:  J Szabó; B Heath; V M Hill; C E Jackson; R J Zarbo; L E Mallette; S L Chew; G M Besser; R V Thakker; V Huff
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

3.  Genome-wide loss of maternal alleles in a nephrogenic rest and Wilms' tumour from a BWS patient.

Authors:  P R Hoban; J Heighway; G R White; B Baker; J Gardner; J M Birch; P Morris-Jones; A M Kelsey
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

4.  Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients.

Authors:  D C Betticher; J Heighway; N Thatcher; P S Hasleton
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.

Authors:  D C Betticher; J Heighway; P S Hasleton; H J Altermatt; W D Ryder; T Cerny; N Thatcher
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.